ReportGem ReportGem 中文

GLOBAL RESEARCH ARCHIVE

European Consumer Staples: India Consumer Health: The next battleground

Published: 2026-06-12Institution: BarclaysPages: 26Original language: 英语Evidence page: 1

Research evidence excerpt

European Consumer Staples: India Consumer Health: The next battleground

Equity Research

European Consumer Staples

12 June 2026

India Consumer Health: The next

battleground

India’s Consumer Health market could be the sector’s next big European Consumer Staples

prize: fast growth, low penetration, rising self-care demand NEUTRAL

and e-commerce acceleration. The Industry remains European Consumer Staples

Warren Ackerman

fragmented but the market is becoming more sophisticated. +44 (0)20 3134 1903

We think Unilever, Haleon and Danone are best placed to warren.ackerman@barclays.com

Barclays, UK

benefit. Alex Sloane

+44 (0)20 3555 0645

We attended the India Consumer Health Summit 2026 on June 10 held in Mumbai organised by alexander.sloane@barclays.com

Nicholas Hall and Sisan Consulting with Haleon as the Lead Partner (Link). It was a broad-based Barclays, UK

gathering of participants across pharmaceuticals, FMCG, global CH companies, digital health Laurence Whyatt

platforms, emerging D2C brands, and investors, which provided a comprehensive view of how +44 (0)20 7773 5324

India’s consumer health market is evolving. laurence.whyatt@barclays.com

The big takeaway is the Indian Consumer Health sector transitioning meaningfully—from a

Abhishek Gokhale

fragmented, product-led market toward a more integrated, consumer-centric and science- +91 (0)22 6175 1952

led ecosystem. We got a closer look at how the Indian consumer is evolving and how trends are abhishek.gokhale@barclays.com

shaping up in the Indian CH market. While structural tailwinds remain compelling— Barclays, UK

demographics, rising health awareness, and digital adoption— some execution challenges

Varshil Modi

around adherence, and regulatory complexity remain. Within this context, we see Haleon and +91 (0)22 6175 3995

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer